322 / 1631
Fewest complications
optimal survivorship
Second cancers
Cardiac toxicity
Pulmonary toxicity
Fertility
Quality of life
Considerations for personalised treatment in
early stage HL
Highest cure rate
with primary therapy
What is the risk of delivering RT (late toxicity) ?
What is the risk of omitting RT (loss of tumour control) ?
What is the optimal therapy for individual patients in balancing risks ?